NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
08/08/2023
Voltar para busca
Dado oficial do USPTO
COMPLEGENT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
08/08/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
40, 42
Data de depósito
30/06/2021
Data de registro
06/12/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/12/2022
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Tokyo, JP
Examinador
MESSICK, TABITHA
Unidade examinadora
L40
Localização atual
TMEG LAW OFFICE 104
Titulares e representantes
Titulares
Kyowa Kirin Co., Ltd.
Representantes
Bassam N. Ibrahim BUCHANAN INGERSOLL & ROONEY PC
Classificação técnica
Classes Nice
Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Contract manufacturing service in the field of antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of host cells; custom manufacturingcontract refiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals; providing information in the field of custom manufacturing in the field of antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of custom manufacturing in the field of antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of custom manufacturing in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of custom manufacturing in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of custom manufacturing in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of custom manufacturing in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of custom manufacturing in the field of host cells; technical consultation in the field of custom manufacturing in the field of host cells; providing technical information in the field of contract manufacturing that consists of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals; technical consultation in the field of manufacturing that consists of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals
Classe 42
Development of new products for others in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells; Providing technical information in the field of development of new products in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells; Technical consultation in the field of development of new products in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
06/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/07/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
21/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
14/11/2022
APET
ASSIGNED TO PETITION STAFF
20/10/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/09/2022
PUBO
PUBLISHED FOR OPPOSITION
20/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/08/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
27/07/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
27/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/07/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/02/2022
GNRT
NON-FINAL ACTION E-MAILED
16/02/2022
CNRT
NON-FINAL ACTION WRITTEN
16/02/2022
DOCK
ASSIGNED TO EXAMINER
09/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2021
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
21/07/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
21/07/2021
NWAP
NEW APPLICATION ENTERED
03/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COMPLEGENT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.